Abstract:Macrophages restrict bacterial infection partly by stimulating phagocytosis and partly by stimulating release of cytokines and complement components. Here, we treat macrophages with LPS and a bacterial pathogen, and demonstrate that expression of cytokine IL-1β and bacterial phagocytosis increase to a transient peak 8 to 12 h post-treatment, while expression of complement component 3 (C3) continues to rise for 24 h post-treatment. Metabolomic analysis suggests a correlation between the cellular concentrations of succinate and IL-1β and of inosine and C3. This may involve a regulatory feedback mechanism, whereby succinate stimulates and inosine inhibits HIF-1α through their competitive interactions with prolyl hydroxylase. Furthermore, increased level of inosine in LPS-stimulated macrophages is linked to accumulation of adenosine monophosphate and that exogenous inosine improves the survival of bacterial pathogen-infected mice and tilapia. The implications of these data suggests potential therapeutic tools to prevent, manage or treat bacterial infections. Bacterial infection is still one of the primary causes of death, especially in the context of exhausted antibiotic reservoir to the growing cases of antibiotic resistance. Novel approach to manage bacterial infection is required. Here, we report a metabolism-based approach to manage immune response to fight against bacterial infection. We find that innate immune response to bacterial infection is constituted with two phases, namely innate cellular immunity and innate humoral immunity. The two phases are interchangeably regulated by two metabolites, inosine and succinate. Succinate promotes the production of inflammatory cytokines IL-1β while inosine downregulates IL-1β expression but increases complement component 3 expression in a time-dependent manner. This is a novel phenomenon that this two-phases innate immune response is required to clear bacterial infection, and is confirmed by the in vivo challenge of mice and fish with pathogenic bacteria in combination of succinate or inosine. We also report a novel mechanism that succinate and inosine competitively regulate HIF-1α activation. Thus, our study presents a novel feedback mechanism of immune response, and inosine could be a potential metabolite in tuning immune response towards bacterial infection.

In situ chemoproteomic profiling reveals itaconate inhibits de novo purine biosynthesis in pathogens

Chemoproteomic profiling of itaconations in <i>Salmonella</i>

Itaconate is a Lysosomal Inducer That Promotes Antibacterial Innate Immunity.

Chemoproteomic Profiling of Itaconation by Bioorthogonal Probes in Inflammatory Macrophages.

Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.

Itaconate Regulates Macrophage Function Through Stressful Iron-Sulfur Cluster Disrupting And Iron Metabolism Rebalancing

S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate

Structural and functional characterization of itaconyl-CoA hydratase and citramalyl-CoA lyase involved in itaconate metabolism of Pseudomonas aeruginosa

Discovery of Itaconate-Mediated Lysine Acylation

A genetically encoded fluorescent biosensor for detecting itaconate with subcellular resolution in living macrophages

Itaconic Acid and Dimethyl Itaconate Exert Antibacterial Activity in Carbon-Enriched Environments Through the TCA Cycle.

Itaconate: A Metabolite Regulates Inflammation Response and Oxidative Stress

4-Octyl Itaconate As a Metabolite Derivative Inhibits Inflammation Via Alkylation of STING

Itaconate Inhibits SYK Through Alkylation and Suppresses Inflammation Against Hvkp Induced Intestinal Dysbiosis.

Itaconic acid exerts anti-inflammatory and antibacterial effects via promoting pentose phosphate pathway to produce ROS

Itaconate stabilizes CPT1a to enhance lipid utilization during inflammation

Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages

Itaconate induces tolerance of Staphylococcus aureus to aminoglycoside antibiotics

The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases

Genome-wide co-essentiality analysis in reveals an itaconate defense enzyme module

Succinate and inosine coordinate innate immune response to bacterial infection